Isis Pharmaceuticals to Present at the Cowen 34th Annual Health Care Conference

[PR Newswire] – CARLSBAD, Calif., Feb. 25, 2014 /PRNewswire/ — Isis Pharmaceuticals, Inc. (ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Cowen and Company 34th Annual Health Care Conf more

View todays social media effects on ISIS

View the latest stocks trending across Twitter. Click to view dashboard

See who Isis is hiring next, click here to view